1,168 reports of this reaction
0.9% of all SALICYLIC ACID reports
#18 most reported adverse reaction
RASH PAPULAR is the #18 most commonly reported adverse reaction for SALICYLIC ACID, manufactured by Alchemee, LLC. There are 1,168 FDA adverse event reports linking SALICYLIC ACID to RASH PAPULAR. This represents approximately 0.9% of all 126,851 adverse event reports for this drug.
SALICYLIC ACID has an overall safety score of 65 out of 100. Patients taking SALICYLIC ACID who experience rash papular should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH PAPULAR is a less commonly reported adverse event for SALICYLIC ACID, but still significant enough to appear in the safety profile.
In addition to rash papular, the following adverse reactions have been reported for SALICYLIC ACID:
The following drugs have also been linked to rash papular in FDA adverse event reports:
RASH PAPULAR has been reported as an adverse event in 1,168 FDA reports for SALICYLIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH PAPULAR accounts for approximately 0.9% of all adverse event reports for SALICYLIC ACID, making it a notable side effect.
If you experience rash papular while taking SALICYLIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.